Under a joint initiative by the Fonds de recherche du Québec and Génome Québec, a task force combining research teams from across the province, including those of the University of Montreal Hospital Research Centre (CRCHUM) and the Université de Montréal, will set up the first Quebec Biobank to advance research efforts studying COVID-19, a disease caused by a new type of virus in the coronaviru

Une nouvelle approche pluridisciplinaire pour dépister et traiter l'amyloïdose

A New Multidisciplinary Approach for Detecting and Treating Amyloidosis

What do heart failure, bruising around the eyes and carpal tunnel syndrome have in common? They are a few of the many signs and symptoms seen in patients with amyloidosis, a rare but often fatal disease for which the CHUM now offers a new treatment approach.

Montreal, November 22, 2019 ─ A hospital corridor has been transformed into an exercise track for patients in the CHUM’s stroke unit, thanks to the new LOCOMOTIVE circuit that provides information and exercises to get patients moving, keep their minds active and encourag

Lauréats des Prix d'excellence 2018

/* AFFICHAGE DESKTOP */ @media screen and (min-width: 768px) { .video { height:380px; width:100%; } .video-mobile {display:none !important;} .banniere-innovaction-mobile {display:none !important;} } .video{ height:375px; width:100%; } .ytp-title { visibility:hidden !important; } /* VERSION MOBILE */ @media only screen and (max-width: 768px) { .contene

Montréal, November 14, 2018 — Today, CHUM and Université de Montréal announce the creation of the first school of artificial intelligence applied to the health sector from a Francophone environment, the École de l'intelligence artificielle en santé du CHUM (EIAS).

Pierrette Gaudreau

On 20 October 2018, Dr. Pierrette Gaudreau , a researcher at, CHUM Research Center (CRCHUM) was awarded the Contribution to Gerontology Award by the Canadian Association on Gerontology (CAG).

Naglaa Shoukry et Thomas Fabre

Naglaa Shoukry, Ph. D., and her team have made a significant breakthrough in their research aiming to limit the progression of liver disease.

Lancement du Consortium

Seeking to improve treatments for 18,000 annual cancer patients, leading researchers, cancer centres and hospitals in Montreal and The Terry Fox Research Institute have partnered to generate new advances in personalized and precision medicine.

The multi-institutional Montreal Cancer Consortium (MCC) comprises the Université de Montréal Hospital Centre Rese

Programme en immunothérapie du cancer

CHUM (Centre hospitalier de l’Université de Montréal) and CRCHUM (its research centre) are now working on a pioneering cancer immunotherapy that employs immune cell infusion. This ground-breaking, personalized approach treats patients using cells taken from their own tumours.

Shalini lal

Lal Shalini, a researcher at the University of Montreal Hospital Research Centre (CRCHUM) and an assistant professor at the Université de Montréal’s School of Rehabilitation, has become the Canada Research Chair in Innovation and Technologies for Youth Mental Health Services.

In Ca